KS
Kanokphong Suparan
Karolinska Institutet, Chiang Mai University, Jožef Stefan International Postgraduate School, Charité – Universitätsmedizin Berlin, Université de Caen Normandie
Research areas: Medicine · Oncology · Gut microbiota and health · Global Cancer Incidence and Screening · Alcohol Consumption and Health Effects
0000-0002-6853-7387
About
Pioneering the impossible – Dr. Suparan has a multidisciplinary background in biomedical research, from molecular biology to clinical epidemiology, with work on microbiota and the Global Burden of Disease. Now focused on bioastronautics, he explores how immunity may adapt to distant exoplanets.
Employment
-
Karolinska Institutet Research Intern2026 - 2026
-
Chiang Mai University Faculty Member2023 - 2025
-
Chiang Mai University Investigator2021 - 2025
-
Chiang Mai University Medical Intern2021 - 2023
Education
-
Jožef Stefan International Postgraduate School Master of Science (Space Medicine Semester 3)2026 - Present
-
Charité - Universitätsmedizin Berlin Master of Science2026 - 2026
-
Université de Caen Normandie Master of Science2025 - 2026
-
Chiang Mai University Doctor of Medicine2015 - 2021
Projects & Funding
Projects & funding information is unavailable.
Publications (49)
- Prognostic Role of Gut Microbiota and Clinical Parameters in Predicting Survival in Advanced Cholangiocarcinoma Patients Receiving Chemotherapy. Save
- Stage-Associated Subgingival Dysbiosis Across the Periodontal Disease Spectrum in a Thai Cohort. Save
- Updated Epidemiology of Gastrointestinal Cancers in the Asia-Pacific: Evidence From GBD 2021 and GLOBOCAN 2022. Save
- Clinical Outcomes of Patients Hospitalized for Conventional Pacemaker Implantation With Protein-Energy Malnutrition. Save
- Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries. Save
- Alterations in the Expression of Let-7i, miR-21-5p, and miR-30b-5p in Plasma-Derived Extracellular Vesicles as the Possible Prognostic Markers in Central Demyelinating Diseases. Save
- Acute coronary syndrome patients exhibit cognitive impairments and gut dysbiosis compared to high cardiovascular risk patients Save
- Global, Regional, and National Disparities in the Burden of Acute Pancreatitis and Alcohol-Related Pancreatitis From 2000 to 2021. Save
- Electroacupuncture alleviates symptoms and identifies a potential microbial biomarker in patients with constipation-predominant irritable bowel syndrome Save
- Evolving Public Attention to Steatotic Liver Disease: A 20‐Year Analysis (2004–2024) Save
- Burden of Alcohol‐Related Liver Disease and Alcohol Use Disorder in Asia Save
- The Rising Global Burden of MASLD and Other Metabolic Diseases (2000–2021) Save
- Early-Onset Gastrointestinal Cancers and Metabolic Risk Factors: Global Trends From the Global Burden of Disease Study 2021 Save
- Larger Fruit Consumption Helps Constipation Patients: Socioeconomic Analysis from 2005 – 2010 NHANES Matched Cohorts Save
- Interruptins Extracted from Cyclosorus terminans Protect Gut Pathologies Induced by High-Fat Diet in Rats Save
- Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021 Save
- Older Adults with Inflammatory Bowel Disease Epidemiology in the United States: 2000–2021 Save
- Young Adults and Alcohol-Associated Liver Cancer: Incidence and Death from 2000 to 2021 Save
- Altered gut microbiome profiles in epileptic children are associated with spectrum of anti-seizure medication responsiveness Save
- Increased MASH-associated liver cancer in younger demographics Save